Patent directory · USPTO A61K / A61P
Patents matching “ARBUTUS BIOPHARMA CORPORATION”
56 pharma patents match "ARBUTUS BIOPHARMA CORPORATION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 56 pharmaceutical patents matching "ARBUTUS BIOPHARMA CORPORATION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11191849
Compositions and methods for delivering messenger RNA
granted -
US 11141378
Lipid formulations for nucleic acid delivery
granted -
US 11130740
Substituted 2,3-dihydro-1H-indene analogs and methods using same
granted -
US 11098010
Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
granted -
US 11077197
Lipids and compositions for the delivery of therapeutics
granted -
US 11013726
Substituted pyridinone-containing trycyclic compounds, and methods using same
granted -
US 11001564
Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
granted -
US 10953095
Lipid compositions
granted -
US 10835612
Lipids and compositions for the delivery of therapeutics
granted -
US 10821186
Lipids and compositions for the delivery of therapeutics
granted -
US 10821103
Substituted pyridinone-containing trycyclic compounds, and methods using same
granted -
US 10653780
Amino lipids and methods for the delivery of nucleic acids
granted -
US 10626393
Delivering CRISPR therapeutics with lipid nanoparticles
granted -
US 10561732
Trialkyl cationic lipids and methods of use thereof
granted -
US 10550084
Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same
granted -
US 10456473
Lipid compositions
granted -
US 10415037
Compositions and methods for silencing hepatitis B virus gene expression
granted -
US 10358447
Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same
granted -
US 10117941
Lipids and compositions for the delivery of therapeutics
granted -
US 10077232
Cyclic cationic lipids and methods of use
granted -
US 10053689
Methods for increasing efficacy of lipid formulated siRNA
granted -
US 9938236
Antiviral agents against HBV infection
granted -
US 9895448
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
granted -
US 9814777
Targeting lipids
granted